Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Science (New York, N.Y.)|September 14, 2002
A major Archean, gold- and crust-forming event in the Kaapvaal craton, South AfricaJason Kirk, Joaquin Ruiz, John Chesley, et al.Advances in Experimental Medicine and Biology|October 3, 2019
Tumor Dormancy and Slow-Cycling Cancer CellsJohn E Davis, Jason Kirk, Yibing Ji, et al.Regulatory Toxicology and Pharmacology : RTP|January 28, 2019
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozinMartin Billger, Jason Kirk, Jane Chang, et al.Nature Communications|May 1, 2020
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancerDingxiao Zhang, Qiang Hu, Xiaozhuo Liu, et al.Oncogene|August 19, 2018
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progressionMark D Long, Prashant K Singh, James R Russell, et al.Toxicology and Applied Pharmacology|March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanismAndrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.Plos Biology|June 27, 2023
A biologist's guide to planning and performing quantitative bioimaging experimentsRebecca A Senft, Barbara Diaz-Rohrer, Pina Colarusso, et al.Cell Reports|December 15, 2021
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancerMark D Long, Justine J Jacobi, Prashant K Singh, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 29, 2014
An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicityLaura Cove-Smith, Neil Woodhouse, Adam Hargreaves, et al.Nature Communications|June 6, 2020
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.Pageof 2